• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从皮肤利什曼病患者中分离出的利什曼原虫的精氨酸酶活性。

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.

作者信息

Badirzadeh A, Taheri T, Abedi-Astaneh F, Taslimi Y, Abdossamadi Z, Montakhab-Yeganeh H, Aghashahi M, Niyyati M, Rafati S

机构信息

Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

出版信息

Parasite Immunol. 2017 Sep;39(9). doi: 10.1111/pim.12454.

DOI:10.1111/pim.12454
PMID:28731592
Abstract

Cutaneous leishmaniasis (CL) is one of the most important vector-borne parasitic diseases, highly endemic in Iran, and its prevalence is increasing all over the country. Arginase (ARG) activity in isolated Leishmania parasites from CL patients is yet to be explored. This study aimed to compare the ARG activity of isolated Leishmania promastigotes from CL patients with a standard strain of Leishmania major and its influences on the disease pathogenesis. We recruited 16 confirmed CL patients from Qom Province, in central Iran; after detection of Leishmania species using PCR-RFLP, we assessed the levels of ARG in the isolated promastigotes and determined the parasites' growth rate. Only L. major was identified from CL patients. The level of ARG activity in the isolated Leishmania promastigotes from CL patients was significantly higher than that obtained from the standard strain of L. major. No significant correlations between ARG activity and lesion size, number or duration were observed; in contrast, a significant negative correlation was seen between ARG level and Leishmania' growth rate. The obtained results suggest that increased ARG expression and activity in the isolated Leishmania promastigotes might contribute to the higher parasite infectivity and play a major role in the pathogenicity of the CL.

摘要

皮肤利什曼病(CL)是最重要的媒介传播寄生虫病之一,在伊朗高度流行,且其患病率在该国各地呈上升趋势。来自CL患者的分离利什曼原虫中的精氨酸酶(ARG)活性尚未得到研究。本研究旨在比较来自CL患者的分离利什曼原鞭毛体与大利什曼原虫标准菌株的ARG活性及其对疾病发病机制的影响。我们从伊朗中部库姆省招募了16名确诊的CL患者;在使用PCR-RFLP检测利什曼原虫种类后,我们评估了分离的前鞭毛体中ARG的水平,并确定了寄生虫的生长速率。从CL患者中仅鉴定出大利什曼原虫。来自CL患者的分离利什曼原鞭毛体中的ARG活性水平显著高于从大利什曼原虫标准菌株获得的水平。未观察到ARG活性与病变大小、数量或持续时间之间存在显著相关性;相反,ARG水平与利什曼原虫的生长速率之间存在显著负相关。所得结果表明,分离的利什曼原鞭毛体中ARG表达和活性的增加可能有助于提高寄生虫的感染性,并在CL的致病性中起主要作用。

相似文献

1
Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.从皮肤利什曼病患者中分离出的利什曼原虫的精氨酸酶活性。
Parasite Immunol. 2017 Sep;39(9). doi: 10.1111/pim.12454.
2
Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity.比较由硕大利什曼原虫和热带利什曼原虫引起的人类急性和慢性皮肤利什曼病,重点关注精氨酸酶活性。
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2118-2121. doi: 10.1111/jdv.13838. Epub 2016 Jul 21.
3
Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.热带利什曼原虫引起的人源化皮肤利什曼病中,葡萄糖酸锑钠治疗无应答和有应答患者外周血单核细胞 TLRs 2、4、9、iNOS 和 TNF-α 的差异表达及精氨酸酶活性。
Microb Pathog. 2019 Jan;126:368-378. doi: 10.1016/j.micpath.2018.11.004. Epub 2018 Nov 3.
4
Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.感染缺乏精氨酸酶的主要利什曼原虫揭示了宿主细胞精氨酸酶活性和疾病发病机制的寄生虫数量依赖性和细胞因子独立性调节。
J Immunol. 2009 Dec 15;183(12):8068-76. doi: 10.4049/jimmunol.0803979.
5
Risk Mapping and Situational Analysis of Cutaneous Leishmaniasis in an Endemic Area of Central Iran: A GIS-Based Survey.伊朗中部一个流行地区皮肤利什曼病的风险地图绘制与态势分析:一项基于地理信息系统的调查
PLoS One. 2016 Aug 30;11(8):e0161317. doi: 10.1371/journal.pone.0161317. eCollection 2016.
6
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.利什曼原虫寄生虫致病和非致病物种中的精氨酸酶活性。
PLoS Negl Trop Dis. 2017 Jul 14;11(7):e0005774. doi: 10.1371/journal.pntd.0005774. eCollection 2017 Jul.
7
[Contribution of Leishmania identification using polymerase chain reaction--restriction fragment length polymerase for epidemiological studies of cutaneous leishmaniasis in Tunisia].[利用聚合酶链反应-限制性片段长度多态性鉴定利什曼原虫对突尼斯皮肤利什曼病流行病学研究的贡献]
Pathol Biol (Paris). 2014 Feb;62(1):30-3. doi: 10.1016/j.patbio.2013.10.004. Epub 2014 Feb 5.
8
An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran.伊朗皮肤利什曼病的诊断和流行病学再评估概述。
Braz J Infect Dis. 2011 Jan-Feb;15(1):17-21.
9
A newly emerged cutaneous leishmaniasis focus in central Iran.伊朗中部新出现的皮肤利什曼病集中区。
Int J Infect Dis. 2013 Dec;17(12):e1198-206. doi: 10.1016/j.ijid.2013.07.003. Epub 2013 Sep 6.
10
Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran.伊朗人兽共患皮肤利什曼病流行区大沙鼠(啮齿目:沙鼠亚科)种群中利什曼原虫感染率的动态变化
Bull Soc Pathol Exot. 2010 May;103(2):84-9. doi: 10.1007/s13149-010-0044-1.

引用本文的文献

1
Selene-Ethylenelacticamides and -Aryl-Propanamides as Broad-Spectrum Leishmanicidal Agents.作为广谱杀利什曼原虫剂的月桂烯乙酰胺和芳基丙酰胺
Pathogens. 2023 Jan 13;12(1):136. doi: 10.3390/pathogens12010136.
2
Cinnamides Target Arginase Selectively.肉桂酰胺类药物选择性靶向精氨酸酶。
Molecules. 2020 Nov 12;25(22):5271. doi: 10.3390/molecules25225271.
3
Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.皮肤利什曼病:宿主对多态寄生虫病的有效免疫反应的复杂性。
J Immunol Res. 2019 Dec 1;2019:2603730. doi: 10.1155/2019/2603730. eCollection 2019.
4
Construction of a Novel DNA Vaccine Candidate encoding LmSTI1-PpSP42 Fusion Protein from and against Cutaneous Leishmaniasis.构建一种新型DNA疫苗候选物,其编码来自[具体来源1]和[具体来源2]的LmSTI1 - PpSP42融合蛋白,用于对抗皮肤利什曼病。
Rep Biochem Mol Biol. 2018 Oct;7(1):67-75.
5
Biomarkers of Cutaneous Leishmaniasis.皮肤利什曼病的生物标志物。
Front Cell Infect Microbiol. 2018 Jun 26;8:222. doi: 10.3389/fcimb.2018.00222. eCollection 2018.
6
Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages?锥虫原生动物感染:寄生虫及其分泌因子如何调节巨噬细胞中 l-精氨酸的诱导代谢?
Front Immunol. 2018 Apr 20;9:778. doi: 10.3389/fimmu.2018.00778. eCollection 2018.
7
First case report of atypical disseminated cutaneous leishmaniasis in an opium abuser in Iran.伊朗一名阿片类药物滥用者患非典型播散性皮肤利什曼病的首例病例报告。
Rev Inst Med Trop Sao Paulo. 2018;60:e5. doi: 10.1590/s1678-9946201860005. Epub 2018 Feb 15.
8
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.人中性粒细胞肽1作为抗利什曼原虫感染的BALB/c小鼠的免疫治疗剂。
PLoS Negl Trop Dis. 2017 Dec 18;11(12):e0006123. doi: 10.1371/journal.pntd.0006123. eCollection 2017 Dec.
9
Case Report: First Coinfection Report of Mixed and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran.病例报告:混合感染 和 人类免疫缺陷病毒获得性免疫缺陷综合征的首次报告:伊朗一例播散性皮肤利什曼病病例报告。
Am J Trop Med Hyg. 2018 Jan;98(1):122-125. doi: 10.4269/ajtmh.17-0490. Epub 2018 Jan 1.